×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
吉林大学白求恩第一... [17]
内容类型
期刊论文 [13]
会议论文 [4]
发表日期
2018 [3]
2017 [3]
2016 [2]
2015 [4]
2014 [3]
2013 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共17条,第1-10条
帮助
限定条件
专题:吉林大学白求恩第一医院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial
期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:
Lu, Shun
;
Wu, Yi-Long
;
Huang, Yunchao
;
Hu, Cheng-Ping
;
Li, Wei
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2019/12/05
afatinib
NSCLC
EGFR
first-line
Phase III
Chinese patients
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab
期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:
Xu, Binghe
;
Ma, Fei
;
Ouyang, Quchang
;
Li, Wei
;
Jiang, Zefei
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:
Zhang, Li
;
Cseh, Agnieszka
;
Peil, Barbara
;
Wang, Jie
;
Feng, Jifeng
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/05
afatinib
NSCLC
squamous cell carcinoma
second-line
Phase III
Chinese patients
Intercalating and maintenance gefitinib plus chemotherapy versus chemotherapy alone in selected advanced non-small cell lung cancer with unknown EGFR status
期刊论文
SCIENTIFIC REPORTS, 2017, 卷号: 7
作者:
Yu, Yongfeng
;
Lu, Shun
;
Li, Wei
;
Ma, Zhiyong
;
Huang, Jianjin
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)
期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 卷号: 13, 期号: 1
作者:
Li, Xiaomei
;
Shi, Yuankai
;
Sun, Yan
;
Yu, Jinming
;
Ding, Cuimin
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2019/12/05
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6
期刊论文
BRITISH JOURNAL OF CANCER, 2017, 卷号: 116, 期号: 2
作者:
Wu, Yi-Long
;
Sequist, Lecia V.
;
Hu, Cheng-Ping
;
Feng, Jifeng
;
Lu, Shun
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
afatinib
circulating cell-free DNA
ErbB family blocker
EGFR mutation
non-small cell lung cancer
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer
期刊论文
BMC CANCER, 2016, 卷号: 16
作者:
Sun, Yan
;
Cheng, Ying
;
Hao, Xuezhi
;
Wang, Jie
;
Hu, Chengping
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
Amrubicin
Cisplatin
Etoposide
ED-SCLC
Randomized clinical trial
Chinese
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study
期刊论文
BMC CANCER, 2016, 卷号: 16
作者:
Wu, Jianqiu
;
Song, Yongping
;
Su, Liping
;
Xu, Li
;
Chen, Tingchao
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/05
DLBCL
R-CHOP
Chemotherapy
HBV infection
HBsAg
Symptom and Quality of Life Improvement in LUX-Lung 6 An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2015, 卷号: 10, 期号: 6
作者:
Geater, Sarayut L.
;
Xu, Chong-Rui
;
Zhou, Caicun
;
Hu, Cheng-Ping
;
Feng, Jifeng
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
Afatinib
Non-small-cell lung cancer
Progression-free survival
Patient-reported outcomes
Quality of life
Intercalating and Maintenance Use of Gefitinib plus Chemotherapy versus Chemotherapy Alone in Selected Advanced NSCLC: A Phase III Study
会议论文
作者:
Huang, Jianjin
;
Jian, Hong
;
Li, Wei
;
Ma, Zhiyong
;
Feng, Jifeng
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
lung adenocarcinoma
gefitinib
chemotherapy
©版权所有 ©2017 CSpace - Powered by
CSpace